Cargando…

Symptomatic and Asymptomatic SARS-CoV-2 Infection and Follow-up of Neutralizing Antibody Levels

OBJECTIVE: To investigate neutralizing antibody levels in symptomatic and asymptomatic patients with coronavirus disease 2019 (COVID-19) at 6 and 10 months after disease onset. METHODS: Blood samples were collected at three different time points from 27 asymptomatic individuals and 69 symptomatic pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	CUI, Shu Juan, ZHANG, Yi, GAO, Wen Jing, WANG, Xiao Li, YANG, Peng, WANG, Quan Yi, PANG, Xing Huo, ZENG, Xiao Peng, LI, Li Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Editorial Board of Biomedical and Environmental Sciences. Published by Elsevier (Singapore) Pte Ltd. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850449/ https://www.ncbi.nlm.nih.gov/pubmed/36597289 http://dx.doi.org/10.3967/bes2022.139

Ejemplares similares

Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
por: Garrido, Carolina, et al.
Publicado: (2021)

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
por: Dufloo, Jérémy, et al.
Publicado: (2021)

Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
por: Marchi, Serena, et al.
Publicado: (2021)

Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
por: Jiang, Chuanhao, et al.
Publicado: (2020)

Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients
por: Chen, Yi, et al.
Publicado: (2021)

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
por: Cao, Yunlong, et al.
Publicado: (2021)

Neuroimaging Features, Follow-Up Analyses, and Comparisons Between Asymptomatic and Symptomatic Neurosyphilis
por: Shang, Xian-Jin, et al.
Publicado: (2020)

Comparison of Clinical and Epidemiological Characteristics of Asymptomatic and Symptomatic SARS-CoV-2 Infection in Children
por: Cai, Jiehao, et al.
Publicado: (2020)

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses
por: Zeng, Lei-Ping, et al.
Publicado: (2017)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
por: Liu, Kuan-Ting, et al.
Publicado: (2022)

Differences in Clinical and Imaging Features between Asymptomatic and Symptomatic COVID-19 Patients
por: Ma, Xi, et al.
Publicado: (2022)

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
por: Reynolds, Catherine J., et al.
Publicado: (2020)

Molecular epidemiology analysis of symptomatic and asymptomatic norovirus infections in Chinese infants
por: Chen, Li-Na, et al.
Publicado: (2023)

LB01 Maternal antibody response and placental antibody transfer following asymptomatic and symptomatic SARS-CoV-2 infection
por: Joseph, Naima T., et al.
Publicado: (2021)

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
por: Dispinseri, Stefania, et al.
Publicado: (2021)

Role of asymptomatic and pre-symptomatic infections in covid-19 pandemic
por: Gao, Wenjing, et al.
Publicado: (2021)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

Ureteroscopic management of asymptomatic and symptomatic simple parapelvic renal cysts
por: Mao, XiaWa, et al.
Publicado: (2015)

Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses
por: Yang, Yong, et al.
Publicado: (2021)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection
por: Sui, Zhiwei, et al.
Publicado: (2021)

SARS-CoV-2 Detected on Environmental Fomites for Both Asymptomatic and Symptomatic Patients with COVID-19
por: Yang, Minghui, et al.
Publicado: (2021)

Norovirus shedding among symptomatic and asymptomatic employees in outbreak settings in Shanghai, China
por: Wu, Qiang-song, et al.
Publicado: (2019)

SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission
por: Corman, Victor M., et al.
Publicado: (2020)

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
por: Feng, Shuo, et al.
Publicado: (2021)

Follow-up of asymptomatic patients with SARS-CoV-2 infection
por: Zhou, X., et al.
Publicado: (2020)

Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants
por: Xu, Hua, et al.
Publicado: (2021)

Track-etched membrane microplate and smartphone immunosensing for SARS-CoV-2 neutralizing antibody
por: Wang, Cong, et al.
Publicado: (2021)

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022)

Previous chronic symptomatic and asymptomatic cerebral hemorrhage in patients with acute ischemic stroke
por: Li, Ge-Fei, et al.
Publicado: (2018)

Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
por: Zhu, Liguo, et al.
Publicado: (2023)

Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo
por: Wang, Qianran, et al.
Publicado: (2022)

Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2
por: Li, W., et al.
Publicado: (2020)

Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes
por: Fu, Dan, et al.
Publicado: (2021)

Functional epitopes and neutralizing antibodies of vaccinia virus
por: Peng, Fenghao, et al.
Publicado: (2023)

The associations between air pollutant exposure and neutralizing antibody titers of an inactivated SARS-CoV-2 vaccine
por: Zhang, Shaocheng, et al.
Publicado: (2021)

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
por: Du, Yanyun, et al.
Publicado: (2021)

Infectivity of asymptomatic versus symptomatic COVID-19
por: Sayampanathan, Andrew A, et al.
Publicado: (2021)

Laboratory analysis of symptomatic and asymptomatic pregnant patients with SARS-CoV-2 infection
por: Fisher, Stephanie A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_00vh0phbsb9n3sstuaehcuhn7t